| Product NDC: | 55390-129 |
| Proprietary Name: | Pamidronate Disodium |
| Non Proprietary Name: | Pamidronate Disodium |
| Active Ingredient(s): | 90 mg/10mL & nbsp; Pamidronate Disodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55390-129 |
| Labeler Name: | Bedford Laboratories |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075290 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20011203 |
| Package NDC: | 55390-129-01 |
| Package Description: | 1 VIAL in 1 BOX, UNIT-DOSE (55390-129-01) > 10 mL in 1 VIAL |
| NDC Code | 55390-129-01 |
| Proprietary Name | Pamidronate Disodium |
| Package Description | 1 VIAL in 1 BOX, UNIT-DOSE (55390-129-01) > 10 mL in 1 VIAL |
| Product NDC | 55390-129 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Pamidronate Disodium |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20011203 |
| Marketing Category Name | ANDA |
| Labeler Name | Bedford Laboratories |
| Substance Name | PAMIDRONATE DISODIUM |
| Strength Number | 90 |
| Strength Unit | mg/10mL |
| Pharmaceutical Classes | Bisphosphonate [EPC],Diphosphonates [Chemical/Ingredient] |